Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rectal Neoplasms × osimertinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 34 Lung Neoplasms 9 Neoplasms 6 Neoplasm Metastasis 5 Carcinoma 5 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thoracic Neoplasms 1 Stage IB-IIIA Non-small Cell Lung Carcinoma 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Noonan Syndrome 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 NSCLC 1 Multiple Myeloma 1 Lymphoma 1 Lung Diseases 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Bronchial Neoplasms 1

Interventions

Oxaliplatin 49 Fluorouracil 45 Leucovorin 42 Capecitabine 40 Irinotecan 31 Bevacizumab 31 Radiotherapy 24 Cetuximab 23 Radiation 13 Panitumumab 13 Folfox protocol 10 Surgical Procedures, Operative 9 IFL protocol 8 Radiotherapy, Intensity-Modulated 6 Magnetic Resonance Spectroscopy 6 aflibercept 5 Immunohistochemistry 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 Fluorodeoxyglucose F18 4 Floxuridine 4 Celecoxib 4 trifluridine tipiracil drug combination 3 dehydroftorafur 3 XELOX 3 Sorafenib 3 Ramucirumab 3 Neoadjuvant Therapy 3 Erlotinib Hydrochloride 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡